| Class Number |
Class Name |
No. of Patents |
| | 7.1 through 7.95 | |
| 435/818 |
Aeration or oxygen transfer technique |
130 |
| 435/974 |
Aids related test |
267 |
| 435/801 |
Anerobic cultivation |
144 |
| 435/325 |
Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore |
9754 |
| 435/326 |
Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof |
634 |
| 435/345 |
Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.) |
112 |
| 435/332 |
Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) |
252 |
| 435/340 |
Binds a bacterium or similar microorganism or component or product thereof (e.g., streptococcus, legionella, mycoplasma, bacterium associated antigen, exotoxin, etc.) |
111 |
| 435/344 |
Binds a cancer cell or component or product thereof (e.g., cell surface antigen, etc.) |
154 |
| 435/344.1 |
Binds an antigen characterized by name or molecular weight (e.g., cea, nca, cc glycoprotein, melanoma gp 150 antigen, etc.) |
181 |
| 435/341 |
Binds a fungus or plant cell or component or product thereof (e.g., fungus associated antigen, etc.) |
24 |
| 435/343 |
Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.) |
139 |
| 435/343.1 |
Binds a lymphocytic or lymphocytic-like cell or component or product thereof (e.g., b cell, b-lineage bone marrow cell, null cell, natural killer cell, b-lymphoblastoid cell, b-lineage, acute lymphoblastic leukemia cell, b-lymphocytic cell surface antigen, etc.) |
119 |
| 435/343.2 |
Binds a t-lymphocytic cell or component or product thereof (e.g., t-cell, thymocyte, t-lineage bone marrow cell, t-lymphoblastoid cell, t-lineage acute lymphoblastic leukemia cell, t-lymphocytic cell surface antigen, etc.) |
111 |
| 435/336 |
Binds a hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.) |
103 |
| 435/335 |
Binds a lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.) |
154 |
| 435/333 |
Binds a nucleic acid or derivative or component thereof (e.g., dna, rna, dna-rna, hybrid, nucleotide, nucleoside, carcinogen-dna adduct, etc.) |
28 |
| 435/342 |
Binds a parasitic protozoan or metazoan cell or component or product thereof; (e.g., dirofilaria, eimeria, coccidia, trichinella, parasite cell surface antigen, etc.) |
38 |
| 435/337 |
Binds a plasma protein, serum protein, or fibrin (e.g., clotting factor fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
120 |
| 435/334 |
Binds a receptor (e.g., transferrin receptor, fc receptor, dihydropyridine receptor, il-2 receptor, etc.) |
269 |
| 435/339 |
Binds a virus or component or product thereof (e.g., virus associated antigen, etc.) |
119 |
| 435/339.1 |
Binds a retrovirus or component or product thereof (e.g., hiv, lav, htlv, etc.) |
106 |
| 435/338 |
Binds an enzyme |
77 |
| 435/331 |
Immunoglobulin or antibody binds a specifically identified amino acid sequence |
253 |
| 435/330 |
Immunoglobulin or antibody binds an expression product of a cancer related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
133 |
| 435/329 |
Immunoglobulin or antibody binds an oligosaccharide structure other than nucleic acid |
83 |
| 435/327 |
Immunoglobulin or antibody is anti-idiotypic |
58 |
| 435/328 |
Immunoglobulin or antibody is chimeric, mutated, or a recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rfv, immunoglobuin fusion protein, etc.) |
286 |
| 435/349 |
Avian cell, per se |
116 |
| 435/350 |
Canine cell, per se |
90 |
| 435/404 |
Culture medium, per se |
248 |
| 435/405 |
Contains a growth factor or growth regulator |
174 |
| 435/406 |
Contains a polypeptide hormone |
80 |
| 435/407 |
Contains an albumin |
46 |
| 435/408 |
Contains an animal extract |
72 |
| 435/351 |
Feline cell, per se |
43 |
| 435/346 |
Fused or hybrid cell, per se |
235 |
| 435/348 |
Insect cell, per se |
619 |
| 435/373 |
Method of co-culturing cells |
280 |
| 435/383 |
Method of culturing cells in suspension |
275 |
| 435/384 |
Culture medium contains a growth factor or growth regulator |
231 |
| 435/385 |
Medium contains a colony stimulating factor |
63 |
| 435/387 |
Medium contains a polypeptide hormone |
67 |
| 435/386 |
Medium contains an interleukin |
68 |
| 435/389 |
Culture medium contains a transferrin |
31 |
| 435/388 |
Culture medium contains an albumin |
26 |
| 435/391 |
Culture medium contains an animal extract |
66 |
| 435/392 |
Serum |
72 |
| 435/390 |
Culture medium contains an incompletely defined plant or microbial extract excluding animal extract |
20 |
| 435/393 |
Using airlift or laminar flow aeration or foam culture |
11 |
| 435/394 |
Wherein culture vessel is rotated or oscillated or culture is agitated |
77 |
| 435/382 |
Method of culturing encapsulated cells |
149 |
| 435/378 |
Method of detaching cells, digesting tissue or establishing a primary culture |
224 |
| 435/381 |
Digesting tissue with protease |
48 |
| 435/380 |
Releasing bound or adhered cell using protease |
41 |
| 435/379 |
Using mechanical means (e.g., trituration, etc.) |
64 |
| 435/375 |
Method of regulating cell metabolism or physiology |
1536 |
| 435/377 |
Method of altering the differentiation state of the cell |
607 |
| 435/376 |
Method of synchronizing cell division |
23 |
| 435/374 |
Method of storing cells in a viable state |
217 |
| 435/363 |
Primate cell, per se |
204 |
| 435/366 |
Human |
1386 |
| 435/372 |
Blood, lymphatic, or bone marrow origin or derivative |
650 |
| 435/372.2 |
B-cell or derivative |
102 |
| 435/372.1 |
Myeloma origin or derivative |
71 |
| 435/372.3 |
T-cell or derivative |
279 |
| 435/371 |
Epithelial origin or derivative |
323 |
| 435/367 |
Hela cell or derivative |
204 |
| 435/370 |
Hepatic origin or derivative |
158 |
| 435/368 |
Nervous system origin or derivative |
243 |
| 435/369 |
Renal origin or derivative |
238 |
| 435/364 |
Monkey kidney |
130 |
| 435/365 |
Cos (e.g., cos-7, etc.) |
327 |
| 435/365.1 |
Expressing recombinant lymphokine, interferon, hormone, growth factor or morphogen |
101 |
| 435/352 |
Rodent cell, per se |
236 |
| 435/358 |
Chinese hamster ovary (i.e., cho) |
410 |
| 435/362 |
Expressing recombinant antigen |
68 |
| 435/360 |
Expressing recombinant hormone or growth factor |
127 |
| 435/361 |
Expressing recombinant receptor |
128 |
| 435/359 |
Expressing recombinant tpa |
37 |
| 435/354 |
Mouse (i.e., mus) |
364 |
| 435/355 |
Blood or lymphatic origin or derivative |
129 |
| 435/357 |
Fibroblast, fibroblast-like cell or derivative (e.g., nih 3t3, etc.) |
187 |
| 435/356 |
L cell or derivative (e.g., ltk(-), etc.) |
83 |
| 435/353 |
Rat (i.e., rattus) |
136 |
| 435/395 |
Solid support and method of culturing cells on said solid support |
540 |
| 435/402 |
Support is a coated or treated surface |
276 |
| 435/398 |
Support is a fiber |
55 |
| 435/399 |
Fabric, mat, gauze, or fibrous coating |
59 |
| 435/400 |
Hollow |
70 |
| 435/397 |
Support is a gel surface |
85 |
| 435/401 |
Support is a membrane |
127 |
| 435/396 |
Support is a resin |
64 |
| 435/403 |
Support is a suspendable particle |
81 |
| 435/347 |
Two or more cell types, per se, in co-culture |
108 |
| 435/283.1 |
Apparatus |
841 |
| 435/289.1 |
Bioreactor |
558 |
| 435/304.1 |
Bottle, tube, jar, or flask |
202 |
| 435/304.3 |
Flat culture flask |
40 |
| 435/304.2 |
Including multiple internal compartments for baffles |
88 |
| 435/296.1 |
Bubble bioreactor |
58 |
| 435/290.1 |
Composting apparatus |
169 |
| 435/290.2 |
Including agitation means |
114 |
| 435/290.3 |
Compostor is rotatably mounted |
65 |
| 435/290.4 |
Including solid or liquid transport means into or out of a compostor |
164 |
| 435/298.1 |
Cylindrical reaction tank or vessel horizontally disposed with respect to its central axis |
47 |
| 435/298.2 |
With a rotatably mounted tank or vessel |
78 |
| 435/305.1 |
Dish, plate, or tray |
181 |
| 435/305.4 |
Including cover seal |
142 |
| 435/305.2 |
Multicompartmented |
201 |
| 435/305.3 |
Including cover seal |
158 |
| 435/295.1 |
Including a draft tube for agitation |
64 |
| 435/295.2 |
Airlift bioreactor |
41 |
| 435/295.3 |
Including a semi-permeable membrane or filter |
28 |
| 435/301.1 |
Including foam breaking means |
26 |
| 435/302.1 |
Including magnetically coupled agitation means |
28 |
| 435/292.1 |
Including means to transmit light into a bioreactor to facilitate photo- bioreaction (e.g., photosynthesis) |
98 |
| 435/300.1 |
Including off-gas trapping means |
91 |
| 435/297.1 |
Including semipermeable membrane or filter |
284 |
| 435/297.5 |
In combination with a dish, plate, or tray |
162 |
| 435/297.2 |
Including perfusion means |
189 |
| 435/297.3 |
Including a spinning semipermeable membrane or filter |
36 |
| 435/297.4 |
Including hollow fiber or capillary |
96 |
| 435/299.1 |
Including solid extended fluid contact reaction surface |
260 |
| 435/299.2 |
Including a bottle, tube, jar, or flask |
55 |
| 435/303.1 |
Incubator |
201 |
| 435/303.3 |
Including an agitator |
31 |
| 435/303.2 |
Specifically adapted for an anaerobic microorganism or enzyme (e.g., anaerobe jars) |
61 |
| 435/291.1 |
Malting or mashing apparatus |
24 |
| 435/291.2 |
Movable floor to facilitate maintenance (e.g., cleaning) |
8 |
| 435/291.3 |
Vertically spaced stages, levels, or floors |
10 |
| 435/291.4 |
Cascading |
8 |
| 435/291.5 |
With agitator or mash turner |
7 |
| 435/291.7 |
With horizontal axis of rotation |
4 |
| 435/291.8 |
Rotating vessel |
3 |
| 435/291.6 |
With vertical axis of rotation |
11 |
| 435/293.1 |
Tubular or plug flow bioreactor |
111 |
| 435/293.2 |
Radial or spiral flow bioreactor |
35 |
| 435/294.1 |
Vessels or trays in series |
135 |
| 435/284.1 |
Differentiated tissue (e.g., organ) perfusion or preservation apparatus |
176 |
| 435/286.1 |
Including condition or time responsive control means |
262 |
| 435/286.6 |
Including gas flow or pressure control |
146 |
| 435/286.5 |
Including liquid flow, level, or volume control |
321 |
| 435/286.7 |
Including mixing or agitation control |
117 |
| 435/286.2 |
Including position control |
118 |
| 435/286.4 |
Including liquid dispenser means |
99 |
| 435/286.3 |
Plater, streaker, or spreader |
39 |
| 435/287.1 |
Including measuring or testing |
1459 |
| 435/288.1 |
Including a bottle, tube, flask, or jar |
278 |
| 435/288.2 |
Including multiple internal compartments or baffles |
165 |
| 435/287.9 |
Including a coated reagent or sample layer |
744 |
| 435/288.3 |
Including a dish, plate, slide, or tray |
467 |
| 435/288.4 |
Including multiple compartments (e.g., wells, etc.) |
634 |
| 435/288.5 |
Including means for fluid passage between compartments (e.g., between wells, etc.) |
398 |
| 435/287.7 |
Including bibulous or absorbent layer |
429 |
| 435/287.8 |
Including multiple, stacked layers |
193 |
| 435/288.6 |
Including column separation means |
107 |
| 435/287.6 |
Including frangible means for introducing a sample or reagent |
110 |
| 435/288.7 |
Including optical measuring or testing means |
969 |
| 435/287.5 |
Means for measuring gas pressure or gas volume of gas evolved from or consumed in an enzymatic or microbial reaction |
105 |
| 435/287.2 |
Measuring or testing for antibody or nucleic acid, or measuring or testing using antibody or nucleic acid |
2066 |
| 435/287.4 |
Sterility testing means |
114 |
| 435/287.3 |
With sample or reagent mechanical transport means |
420 |
| 435/309.1 |
Inoculator, streaker, or sampler |
229 |
| 435/309.3 |
Loop or wire streaker |
14 |
| 435/309.2 |
Means for inoculation or sampling of a closed vessel |
63 |
| 435/309.4 |
Replica plate |
36 |
| 435/306.1 |
Involving lysis of a microorganism by means other than comminution |
81 |
| 435/308.1 |
Means for separation or recovery of a microorganism from culture media |
149 |
| 435/307.1 |
Microorganism preservation, storage, or transport apparatus |
210 |
| 435/285.1 |
Mutation or genetic engineering apparatus |
140 |
| 435/285.3 |
Including projectile means |
28 |
| 435/285.2 |
With means for applying an electric current or charge (e.g., electrofusion, electroporation, etc.) |
228 |
| 435/971 |
Capture of complex after antigen-antibody reaction |
181 |
| 435/174 |
Carrier-bound or immobilized enzyme or microbial cell; carrier-bound or immobilized cell; preparation thereof |
979 |
| 435/176 |
Enzyme or microbial cell is immobilized on or in an inorganic carrier |
727 |
| 435/177 |
Enzyme or microbial cell is immobilized on or in an organic carrier |
976 |
| 435/178 |
Carrier is carbohydrate |
518 |
| 435/179 |
Carbohydrate is cellulose or derivative thereof |
307 |
| 435/180 |
Carrier is synthetic polymer |
1071 |
| 435/181 |
Attached to the carrier via a bridging agent |
512 |
| 435/182 |
Enzyme or microbial cell is entrapped within the carrier (e.g., gel, hollow fibre) |
650 |
| 435/175 |
Multi-enzyme system |
137 |
| 435/DIG.1 |
Combinatorial chemistry and library technology |
72 |
| 435/DIG.43 |
Apparatus |
22 |
| 435/DIG.44 |
For preparing libraries |
18 |
| 435/DIG.45 |
For screening |
14 |
| 435/DIG.22 |
Library or combinatorial chemistry related product |
30 |
| 435/DIG.23 |
Library of biologically replicable entities (e.g., genetic packages, vectors, etc.) or a biologically replicable entity (e.g., genetic packages, vectors, etc.) displaying, containing or presenting the library elements |
16 |
| 435/DIG.25 |
The entity is a microorganism, animal cell or plant cell |
0 |
| 435/DIG.26 |
Animal cell |
2 |
| 435/DIG.28 |
Bacteria or protozoa |
2 |
| 435/DIG.27 |
Yeast or fungus |
2 |
| 435/DIG.24 |
The entity is a virus or bacteriophage |
9 |
| 435/DIG.29 |
Library of inorganic compounds or materials |
8 |
| 435/DIG.30 |
The compound or material is a catalyst |
4 |
| 435/DIG.31 |
The compound or material is metal containing |
2 |
| 435/DIG.32 |
Alloy |
1 |
| 435/DIG.33 |
Metal oxide |
2 |
| 435/DIG.34 |
Library of organic compounds or materials |
46 |
| 435/DIG.38 |
The compound or material is a carbohydrate or derivative thereof |
4 |
| 435/DIG.37 |
The compound or material is a nucleotide or a polynucleotide or derivative thereof |
24 |
| 435/DIG.35 |
The compound or material is a peptide or a polypeptide or derivative thereof |
31 |
| 435/DIG.36 |
Peptide nucleic acid (i.e., pna) |
4 |
| 435/DIG.39 |
The compound or material is a polymer |
5 |
| 435/DIG.42 |
Linking agent for connecting support to library element |
12 |
| 435/DIG.40 |
Support |
38 |
| 435/DIG.41 |
Tagging, encoding or labeling agent or material (e.g., microchip transponders, etc.) |
14 |
| 435/DIG.46 |
Method of making a library |
32 |
| 435/DIG.50 |
Employing solution phase synthesis not utilizing a support |
9 |
| 435/DIG.47 |
Using biological means (e.g., using enzyme, microorganism, cell, cellular genetic component, etc.) |
17 |
| 435/DIG.51 |
Virtual method of making, designing or optimizing a library |
9 |
| 435/DIG.49 |
Wherein library members are bound to a solid support |
57 |
| 435/DIG.48 |
Wherein library members are bound to a soluble support |
10 |
| 435/DIG.2 |
Method of screening a library |
59 |
| 435/DIG.3 |
Involving a biologically replicable entity (e.g., genetic package, vector, etc.) which is the library, displays the library, contains the library or presents the library |
37 |
| 435/DIG.5 |
The entity is a microorganism, animal cell or plant cell |
11 |
| 435/DIG.6 |
Animal cell |
8 |
| 435/DIG.8 |
Bacteria or protozoa |
4 |
| 435/DIG.7 |
Yeast or fungus |
8 |
| 435/DIG.4 |
The entity is a virus or bacteriophage |
32 |
| 435/DIG.9 |
Screening a library of inorganic compounds or materials |
17 |
| 435/DIG.10 |
Screening for catalytic activity |
9 |
| 435/DIG.11 |
The compound or material is metal containing |
6 |
| 435/DIG.12 |
Alloy |
5 |
| 435/DIG.13 |
Metal oxide |
5 |
| 435/DIG.14 |
Screening a library of organic compounds or materials |
76 |
| 435/DIG.18 |
The compound or material is a carbohydrate or derivative thereof |
12 |
| 435/DIG.17 |
The compound or material is a nucleotide or a polynucleotide or derivative thereof |
42 |
| 435/DIG.15 |
The compound or material is a peptide or a polypeptide or derivative thereof |
59 |
| 435/DIG.16 |
Peptide nucleic acid (i.e., pna) |
12 |
| 435/DIG.19 |
The compound or material is a polymer |
7 |
| 435/DIG.21 |
Using deconvolution (e.g., tagging or encoding methodology, etc.) |
9 |
| 435/DIG.20 |
Virtual/computer based screening method (e.g., using crystallographic coordinates of a target, etc.) |
5 |
| 435/3 |
Condition responsive control process |
184 |
| 435/813 |
Continuous fermentation |
326 |
| 435/1.1 |
Differentiated tissue or organ other than blood, per se, or differentiated tissue or organ maintaining; composition therefor |
473 |
| 435/1.3 |
Including freezing; composition therefor |
182 |
| 435/1.2 |
Including perfusion; composition therefor |
177 |
| 435/800 |
Elimination or reduction of contamination by undersired ferments (e.g., aseptic cultivation) |
90 |
| 435/183 |
Enzyme (e.g., ligases (6. ), etc.), proenzyme; compositions thereof; process for preparing, activating, inhibiting, separating, or purifying enzymes |
2634 |
| 435/188.5 |
Catalytic antibody |
126 |
| 435/184 |
Enzyme inactivation by chemical treatment |
415 |
| 435/195 |
Hydrolase (3. ) |
706 |
| 435/227 |
Acting on carbon to nitrogen bond other than peptide bond (3.5) |
259 |
| 435/228 |
Acting on a linear amide linkage in linear amide |
186 |
| 435/229 |
Asparaginase |
26 |
| 435/230 |
Penicillin amidase |
55 |
| 435/231 |
Acting on amide linkage in cyclic amides (e.g., penicillinase, etc.) (3.5.2) |
61 |
| 435/196 |
Acting on ester bond (3.1) |
794 |
| 435/197 |
Carboxylic ester hydrolase (3.1.1) |
287 |
| 435/198 |
Triglyceride splitting (e.g., lipase, etc. (3.1.1.3)) |
486 |
| 435/199 |
Ribonuclease (3.1.4) |
425 |
| 435/200 |
Acting on glycosyl compound (3.2) |
711 |
| 435/201 |
Acting on alpha-1, 4-glucosidic bond, (e.g., hyaluronidase, invertase, amylase, etc. (some 3.2.1)) |
334 |
| 435/202 |
Alpha-amylase, microbial source |
214 |
| 435/203 |
Fungal source |
97 |
| 435/204 |
Alpha-amylase, plant source (3.2.1.1) |
98 |
| 435/205 |
Glucoamylase (3.2.1.3) |
122 |
| 435/210 |
Acting on alpha-1, 6-glucosidic bond (e.g., isoamylase, pullulanase, etc.) |
121 |
| 435/211 |
Dextranase (3.2.1.11) |
29 |
| 435/208 |
Acting on alpha-galatose-glycoside bond (e.g., alpha-galactosidase, etc.) |
101 |
| 435/206 |
Acting on beta-1, 4 link between n-acetylmuramic acid and 2-acetylamino 2 deoxy-d-glucose (e.g., lysozyme, etc.) |
109 |
| 435/209 |
Acting on beta-1, 4-glucosidic bond (e.g., cellulase, etc. (3.2.1.4)) |
438 |
| 435/207 |
Acting on beta-galatose-glycoside bond (e.g., beta-galactosidase, etc.) |
142 |
| 435/212 |
Acting on peptide bond (e.g., thromboplastin, leucine amino-peptidase, etc., (3.4)) |
872 |
| 435/218 |
Elastase |
70 |
| 435/217 |
Plasmin (i.e., fibrinolysin) |
106 |
| 435/219 |
Proteinase |
836 |
| 435/226 |
Derived from animal tissue (e.g., rennin, etc.) |
698 |
| 435/220 |
Derived from bacteria |
338 |
| 435/221 |
Bacteria is bacillus |
277 |
| 435/222 |
Bacillus subtilus or bacillus lichenoformis |
204 |
| 435/223 |
Derived from fungi |
97 |
| 435/225 |
From aspergillus |
67 |
| 435/224 |
From yeast |
55 |
| 435/216 |
Streptokinase |
75 |
| 435/214 |
Thrombin |
111 |
| 435/213 |
Trypsin; chymotrypsin |
127 |
| 435/215 |
Urokinase |
178 |
| 435/233 |
Isomerase (5. ) |
237 |
| 435/234 |
Glucose isomerase |
105 |
| 435/232 |
Lyase (4. ) |
534 |
| 435/185 |
Malt |
24 |
| 435/189 |
Oxidoreductase (1. ) (e.g., luciferase) |
1227 |
| 435/190 |
Acting on choh group as donor (e.g., glucose oxidase, lactate dehydrogenase (1.1)) |
620 |
| 435/192 |
Acting on hydrogen peroxide as acceptor (1.11) |
268 |
| 435/191 |
Acting on nitrogen-containing compound as donor (1.2, 1.5, 1.7) |
248 |
| 435/186 |
Pancreatin |
11 |
| 435/187 |
Preparing granular- or free-flowing enzyme composition |
100 |
| 435/188 |
Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate |
1193 |
| 435/193 |
Transferase other than ribonuclease (2.) |
1516 |
| 435/194 |
Transferring phosphorus containing group (e.g., kineases, etc.(2.7)) |
1492 |
| 435/817 |
Enzyme or microbe electrode |
523 |
| 435/814 |
Enzyme separation or purification |
249 |
| 435/816 |
By solubility |
112 |
| 435/815 |
By sorption |
250 |
| 435/819 |
Fermentation vessels in series |
82 |
| 435/806 |
Fertility tests |
56 |
| 435/812 |
Foam control |
60 |
| 435/807 |
Gas detection apparatus |
85 |
| 435/968 |
High energy substrates (e.g., fluorescent, chemiluminescent, radioactive, etc.) |
576 |
| 435/960 |
Immunohistochemical assay |
208 |
| 435/961 |
Including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen, per se |
272 |
| 435/964 |
Including enzyme-ligand conjugate production (e.g., reducing rate of nonproductive linkage, etc.) |
108 |
| 435/809 |
Incubators or racks or holders for culture plates or containers |
208 |
| 435/811 |
Interferon |
154 |
| 435/966 |
Involving an enzyme system with high turnover rate or complement magnified assay (e.g., multi-enzyme systems, etc.) |
100 |
| 435/965 |
Involving idiotype or anti-idiotype antibody |
37 |
| 435/975 |
Kit |
1516 |
| 435/802 |
Logarithmic growth phase |
26 |
| 435/2 |
Maintaining blood or sperm in a physiologically active state or compositions thereof or therefor or methods of in vitro blood cell separation or treatment |
1410 |
| 435/4 |
Measuring or testing process involving enzymes or micro-organisms; composition or test strip therefore; processes of forming such composition or test strip |
4809 |
| 435/9 |
Geomicrobiological testing (e.g., for petroleum, etc.) |
38 |
| 435/7.1 |
Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay |
8226 |
| 435/7.7 |
Assay in which a label present is an apoenzyme, prosthetic group, or enzyme cofactor |
204 |
| 435/7.71 |
Assay in which a label present is an enzyme inhibitor or functions to alter enzyme activity |
184 |
| 435/7.72 |
Assay in which a label present is an enzyme substrate or substrate analogue |
372 |
| 435/7.9 |
Assay in which an enzyme present is a label |
1602 |
| 435/7.91 |
Enzyme produces product which is part of another reaction system (e.g., cyclic reaction, cascade reaction, etc.) |
371 |
| 435/7.92 |
Heterogeneous or solid phase assay system (e.g., elisa, etc.) |
2835 |
| 435/7.93 |
Competitive assay |
1254 |
| 435/7.95 |
Indirect assay |
777 |
| 435/7.94 |
Sandwich assay |
1476 |
| 435/7.2 |
Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate |
2595 |
| 435/7.21 |
Animal cell |
2415 |
| 435/7.25 |
Erythrocyte |
324 |
| 435/7.24 |
Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.) |
998 |
| 435/7.22 |
Parasite or protozoa |
259 |
| 435/7.23 |
Tumor cell or cancer cell |
1505 |
| 435/7.32 |
Bacteria or actinomycetales |
844 |
| 435/7.37 |
Escherichia coli |
131 |
| 435/7.35 |
Salmonella |
72 |
| 435/7.36 |
Sexually transmitted disease (e.g., chlamydia, syphilis, gonorrhea, etc.) |
174 |
| 435/7.33 |
Staphylococcus |
86 |
| 435/7.34 |
Streptococcus |
138 |
| 435/7.3 |
Flagellar-antigen or pili-antigen |
60 |
| 435/7.31 |
Fungi (e.g., yeast, mold, etc.) |
275 |
| 435/7.6 |
Involving a modified enzyme (e.g., abzyme, recombinant, chemically altered, etc.) |
250 |
| 435/7.5 |
Involving avidin-biotin binding |
691 |
| 435/7.8 |
Involving nonmembrane bound receptor binding or protein binding other than antigen-antibody binding |
763 |
| 435/7.4 |
To identify an enzyme or isoenzyme |
896 |
| 435/13 |
Involving blood clotting factor (e.g., involving thrombin, thromboplastin, fibrinogen, etc.) |
552 |
| 435/11 |
Involving cholesterol |
304 |
| 435/40.5 |
Involving fixed or stabilized, nonliving microorganism, cell, or tissue (e.g., processes of staining, stabilizing, dehydrating, etc.; compositions used therefore, etc.) |
415 |
| 435/40.51 |
Involving a monolayer, smear or suspension of microorganisms or cells |
232 |
| 435/40.52 |
Involving tissue sections |
232 |
| 435/14 |
Involving glucose or galactose |
894 |
| 435/18 |
Involving hydrolase |
1084 |
| 435/22 |
Involving amylase |
188 |
| 435/19 |
Involving esterase |
546 |
| 435/20 |
Involving cholinesterase |
92 |
| 435/21 |
Involving phosphatase |
606 |
| 435/24 |
Involving peptidase |
525 |
| 435/23 |
Involving proteinase |
937 |
| 435/8 |
Involving luciferase |
356 |
| 435/6 |
Involving nucleic acid |
17944 |
| 435/25 |
Involving oxidoreductase |
1113 |
| 435/27 |
Involving catalase |
122 |
| 435/26 |
Involving dehydrogenase |
666 |
| 435/28 |
Involving peroxidase |
956 |
| 435/15 |
Involving transferase |
1048 |
| 435/17 |
Involving creatine phosphokinase |
168 |
| 435/16 |
Involving transaminase |
155 |
| 435/12 |
Involving urea or urease |
182 |
| 435/10 |
Involving uric acid |
117 |
| 435/29 |
Involving viable micro-organism |
2201 |
| 435/34 |
Determining presence or kind of micro-organism; use of selective media |
1331 |
| 435/38 |
Enterobacteria |
162 |
| 435/37 |
Nitrate to nitrite reducing bacteria |
51 |
| 435/39 |
Quantitative determination |
387 |
| 435/40 |
Using multifield media |
55 |
| 435/36 |
Streptococcus; staphylococcus |
110 |
| 435/35 |
Using radioactive material |
125 |
| 435/30 |
Methods of sampling or inoculating or spreading a sample; methods of physically isolating an intact micro-organism |
542 |
| 435/32 |
Testing for antimicrobial activity of a material |
576 |
| 435/33 |
Using multifield media |
99 |
| 435/31 |
Testing for sterility condition |
207 |
| 435/5 |
Involving virus or bacteriophage |
3671 |
| 435/963 |
Methods of stopping an enzyme reaction or stabilizing the test materials |
128 |
| | Micro-organism cross-reference art collections | |
| 435/946 |
Using algae |
113 |
| 435/822 |
Using bacteria or actinomycetales |
923 |
| 435/823 |
Acetobacter |
88 |
| 435/824 |
Achromobacter |
54 |
| 435/825 |
Actinomadura |
48 |
| 435/826 |
Actinomyces |
38 |
| 435/827 |
Actinoplanes |
51 |
| 435/828 |
Aerobacter |
23 |
| 435/829 |
Alcaligenes |
131 |
| 435/830 |
Arthrobacter |
140 |
| 435/831 |
Azotobacter |
29 |
| 435/832 |
Bacillus |
435 |
| 435/833 |
Bacillus brevis |
19 |
| 435/834 |
Bacillus cereus |
57 |
| 435/835 |
Bacillus circulans |
31 |
| 435/836 |
Bacillus licheniformis |
74 |
| 435/837 |
Bacillus megaterium |
34 |
| 435/838 |
Bacillus polymyxa |
25 |
| 435/839 |
Bacillus subtilis |
204 |
| 435/840 |
Brevibacterium |
159 |
| 435/841 |
Chainia |
1 |
| 435/842 |
Clostridium |
118 |
| 435/843 |
Corynebacterium |
192 |
| 435/844 |
Corynebacterium diphtheriae |
4 |
| 435/845 |
Corynebacterium poinsettiae |
1 |
| 435/846 |
Corynebacterium pyogenes |
1 |
| 435/847 |
Erwinia |
58 |
| 435/848 |
Escherichia |
58 |
| 435/849 |
Escherichia coli |
341 |
| 435/850 |
Flavobacterium |
65 |
| 435/851 |
Haemophilus |
28 |
| 435/852 |
Klebsiella |
78 |
| 435/853 |
Lactobacillus |
158 |
| 435/854 |
Lactobacillus acidophilus |
48 |
| 435/855 |
Lactobacillus brevis |
23 |
| 435/856 |
Lactobacillus casei |
44 |
| 435/857 |
Lactobacillus plantarum |
42 |
| 435/858 |
Methylomonas |
27 |
| 435/859 |
Micrococcus |
57 |
| 435/860 |
Micrococcus flavus |
2 |
| 435/861 |
Micrococcus glutamicus |
3 |
| 435/862 |
Micrococcus lysodeikticus |
5 |
| 435/867 |
Micromonospora |
33 |
| 435/868 |
Micromonospora chalcea |
11 |
| 435/869 |
Micromonospora purpurea |
9 |
| 435/863 |
Mycobacterium |
131 |
| 435/864 |
Mycobacterium avium |
23 |
| 435/865 |
Mycobacterium fortuitum |
38 |
| 435/866 |
Mycobacterium smegmatis |
42 |
| 435/870 |
Mycoplasma |
33 |
| 435/871 |
Neisseria |
62 |
| 435/872 |
Nocardia |
154 |
| 435/873 |
Proteus |
57 |
| 435/874 |
Pseudomonas |
393 |
| 435/875 |
Pseudomonas aeruginosa |
88 |
| 435/876 |
Pseudomonas fluorescens |
93 |
| 435/877 |
Pseudomonas putida |
148 |
| 435/878 |
Rhizobium |
56 |
| 435/879 |
Salmonella |
74 |
| 435/880 |
Serratia |
44 |
| 435/881 |
Serratia marcescens |
39 |
| 435/882 |
Staphylococcus |
58 |
| 435/883 |
Staphylococcus aureus |
73 |
| 435/884 |
Staphylococcus epidermidis |
24 |
| 435/885 |
Streptococcus |
198 |
| 435/886 |
Streptomyces |
548 |
| 435/887 |
Streptomyces albus |
14 |
| 435/888 |
Streptomyces antibioticus |
17 |
| 435/889 |
Streptomyces aureofaciens |
16 |
| 435/890 |
Streptomyces aureus |
4 |
| 435/891 |
Streptomyces bikiniensia |
2 |
| 435/892 |
Streptomyces candidus |
5 |
| 435/893 |
Streptomyces chartreusis |
13 |
| 435/894 |
Streptomyces diastatochromogenes |
1 |
| 435/895 |
Streptomyces filipinensis |
2 |
| 435/896 |
Streptomyces fradiae |
33 |
| 435/897 |
Streptomyces griseus |
34 |
| 435/898 |
Streptomyces hygroscopicus |
42 |
| 435/899 |
Streptomyces lavendulae |
13 |
| 435/900 |
Streptomyces lincolnensis |
3 |
| 435/901 |
Streptomyces noursei |
1 |
| 435/902 |
Streptomyces olivaceus |
12 |
| 435/903 |
Streptomyces platensis |
2 |
| 435/904 |
Streptomyces rimosus |
6 |
| 435/905 |
Streptomyces sparogenes |
2 |
| 435/906 |
Streptomyces venezuelae |
7 |
| 435/907 |
Streptosporangium |
12 |
| 435/908 |
Streptovirticillium |
14 |
| 435/909 |
Vibrio |
48 |
| 435/910 |
Xanthomonas |
91 |
| 435/911 |
Using fungi |
734 |
| 435/912 |
Absidia |
29 |
| 435/913 |
Aspergillus |
112 |
| 435/914 |
Aspergillus awamori |
6 |
| 435/915 |
Aspergillus flavus |
12 |
| 435/916 |
Aspergillus fumigatus |
11 |
| 435/917 |
Aspergillus niger |
108 |
| 435/918 |
Aspergillus oryzae |
31 |
| 435/919 |
Aspergillus ustus |
2 |
| 435/920 |
Aspergillus wenti |
4 |
| 435/921 |
Candida |
188 |
| 435/922 |
Candida albicans |
42 |
| 435/923 |
Candida lipolytica |
48 |
| 435/924 |
Candida tropicalis |
43 |
| 435/925 |
Cephalosporium |
9 |
| 435/926 |
Cephalosporium acremonium |
10 |
| 435/927 |
Cephalosporium caerulens |
0 |
| 435/928 |
Cephalosporium crotocinigenium |
0 |
| 435/929 |
Fusarium |
62 |
| 435/930 |
Hansenula |
37 |
| 435/931 |
Mucor |
64 |
| 435/932 |
Paecilomyces |
14 |
| 435/933 |
Penicillium |
70 |
| 435/934 |
Penicillium brevi |
1 |
| 435/935 |
Penicillium chrysogenum |
24 |
| 435/936 |
Penicillium notatium |
4 |
| 435/937 |
Penicillium patulum |
1 |
| 435/938 |
Pichia |
82 |
| 435/939 |
Rhizopus |
60 |
| 435/940 |
Saccharomyces |
95 |
| 435/941 |
Saccharomyces carlsbergensis |
13 |
| 435/942 |
Saccharomyces cerevisiae |
179 |
| 435/943 |
Saccharomyces lactis |
6 |
| 435/944 |
Torulopsis |
37 |
| 435/945 |
Trichoderma |
72 |
| 435/947 |
Using protozoa |
58 |
| 435/948 |
Using viruses or cell lines |
431 |
| 435/243 |
Micro-organism, per se (e.g., protozoa, etc.); compositions thereof; proces of propagating, maintaining or preserving micro-organisms or compositions thereof; process of preparing or isolating a composition containing a micro-organism; culture media therefor |
1486 |
| 435/245 |
Adaptation or attenuation of cells |
171 |
| 435/257.1 |
Algae, media therefor |
125 |
| 435/257.6 |
Chlamydomonas |
10 |
| 435/257.3 |
Chlorella |
38 |
| 435/257.4 |
Euglena |
7 |
| 435/257.5 |
Scenedesmus |
4 |
| 435/257.2 |
Transformants |
63 |
| 435/252.1 |
Bacteria or actinomycetales; media therefor |
1798 |
| 435/252.6 |
Actinoplanes |
27 |
| 435/252.5 |
Bacillus (e.g., b. subtilis, b. thuringiensis, etc.) |
507 |
| 435/252.7 |
Clostridium |
101 |
| 435/253.6 |
Culture media, per se |
227 |
| 435/252.8 |
Escherichia (e.g., e. coli, etc.) or salmonella |
370 |
| 435/252.9 |
Lactobacillus, pediococcus, or leuconostoc |
298 |
| 435/252.4 |
Mixed culture |
222 |
| 435/253.1 |
Mycobacterium |
188 |
| 435/253.2 |
Nocardia |
69 |
| 435/253.3 |
Pseudomonas |
339 |
| 435/252.2 |
Rhizobium or agrobacterium |
245 |
| 435/253.4 |
Streptococcus |
193 |
| 435/253.5 |
Streptomyces |
270 |
| 435/252.3 |
Transformants (e.g., recombinant dna or vector or foreign or exogenous gene containing, fused bacteria, etc.) |
9734 |
| 435/252.31 |
Bacillus (e.g., b. subtilis, b. thuringiensis, etc.) |
722 |
| 435/252.32 |
Brevibacterium or corynebacterium |
262 |
| 435/252.33 |
Escherichia (e.g., e. coli, etc.) |
2846 |
| 435/252.34 |
Pseudomonas |
249 |
| 435/252.35 |
Streptomyces |
322 |
| 435/244 |
Chemical stimulation of growth or activity by addition of chemical compound which is not an essential growth factor; stimulation of growth by removal of a chemical compound |
415 |
| 435/246 |
Foam culture |
32 |
| 435/254.1 |
Fungi |
786 |
| 435/256.1 |
Aspergillus |
94 |
| 435/256.4 |
Cephalosporium or acremonium |
10 |
| 435/256.8 |
Culture media, per se, or technique |
129 |
| 435/256.5 |
Fusarium |
30 |
| 435/256.2 |
Mucor |
7 |
| 435/256.3 |
Penicillium |
45 |
| 435/256.6 |
Rhizopus |
16 |
| 435/254.11 |
Transformants |
1811 |
| 435/254.3 |
Aspergillus |
280 |
| 435/254.7 |
Fusarium |
47 |
| 435/254.8 |
Mucor |
22 |
| 435/254.4 |
Neurospora |
54 |
| 435/254.5 |
Penicillium |
68 |
| 435/254.9 |
Rhizopus |
19 |
| 435/254.6 |
Trichoderma |
99 |
| 435/254.2 |
Yeast; media therefor |
1042 |
| 435/254.22 |
Candida |
127 |
| 435/254.23 |
Pichia |
162 |
| 435/254.21 |
Saccharomyces |
604 |
| 435/256.7 |
Trichoderma |
44 |
| 435/255.1 |
Yeast |
371 |
| 435/255.4 |
Candida or torulopsis |
125 |
| 435/255.3 |
Cryptococcus |
19 |
| 435/255.7 |
Culture media, per se, or technique |
49 |
| 435/255.6 |
Hansenula |
27 |
| 435/255.5 |
Pichia |
69 |
| 435/255.2 |
Saccharomyces |
209 |
| 435/255.21 |
Culture media, per se, or technique |
78 |
| 435/259 |
Lysis of micro-organism |
255 |
| 435/260 |
Preserving or maintaining micro-organism |
252 |
| 435/258.1 |
Protozoa, media therefor |
76 |
| 435/258.4 |
Eimeria |
17 |
| 435/258.3 |
Leishmania |
21 |
| 435/258.2 |
Plasmodium |
11 |
| 435/261 |
Separation of micro-organism from culture media |
220 |
| 435/252 |
Utilizing media containing cellulose or hydrolysates thereof |
119 |
| 435/248 |
Utilizing media containing hydrocarbon |
89 |
| 435/249 |
Aliphatic |
51 |
| 435/250 |
Having five or less carbon atoms |
28 |
| 435/247 |
Utilizing media containing lower alkanol (i.e., having one to six carbon atoms) |
94 |
| 435/251 |
Utilizing media containing waste sulphite liquor |
19 |
| 435/41 |
Micro-organism, tissue cell culture or enzyme using process to synthesize a desired chemical compound or composition |
943 |
| 435/68.1 |
Enzymatic production of a protein or polypeptide (e.g., enzymatic hydrolysis, etc.) |
956 |
| 435/106 |
Preparing alpha or beta amino acid or substituted amino acid or salts thereof |
468 |
| 435/116 |
Alanine; leucine; isoleucine; serine; homoserine |
171 |
| 435/109 |
Aspartic acid (asparaginic acid); asparagine |
103 |
| 435/114 |
Citrulline; arginine; ornithine |
71 |
| 435/110 |
Glutamic acid; glutamine |
145 |
| 435/111 |
Utilizing biotin or its derivatives |
20 |
| 435/112 |
Utilizing surfactant fatty acids or fatty acid esters (i.e., having seven or more atoms) |
16 |
| 435/115 |
Lysine; diaminopimelic acid; threonine; valine |
276 |
| 435/113 |
Methionine; cysteine; cystine |
115 |
| 435/107 |
Proline; hydroxyproline; histidine |
91 |
| 435/108 |
Tryptophan; tyrosine; phenylalanine; 3,4 dihydroxyphenylalanine |
213 |
| 435/67 |
Preparing compound containing a carotene nucleus (i.e., carotene) |
126 |
| 435/52 |
Preparing compound containing a cyclopentanohydrophenanthrene nucleus; nor-, homo-, or d-ring lactone derivatives thereof |
96 |
| 435/54 |
Acting on d-ring |
9 |
| 435/55 |
Acting at 17-position |
57 |
| 435/56 |
Hydroxylating at 17-position |
19 |
| 435/57 |
Hydroxylating at 16-position |
4 |
| 435/53 |
Containing heterocyclic ring |
25 |
| 435/61 |
Dehydrogenating; dehydroxylating |
38 |
| 435/62 |
Forming an aryl ring from "a" ring |
2 |
| 435/58 |
Hydroxylating |
43 |
| 435/59 |
At 11-position |
16 |
| 435/60 |
At 11 alpha position |
13 |
| 435/63 |
Preparing compound containing a prostaglandin nucleus |
40 |
| 435/127 |
Preparing compound containing at least three carbocyclic rings |
59 |
| 435/72 |
Preparing compound containing saccharide radical |
321 |
| 435/100 |
Disaccharide |
217 |
| 435/93 |
Mashing or wort making |
45 |
| 435/105 |
Monosaccharide |
294 |
| 435/101 |
Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds |
837 |
| 435/103 |
Dextran |
40 |
| 435/102 |
Pullulan |
22 |
| 435/104 |
Xanthan; i.e., xanthomonas-type heteropolysaccharides |
149 |
| 435/84 |
Preparing nitrogen-containing saccharide |
180 |
| 435/85 |
N-glycoside |
94 |
| 435/86 |
Cobalamin (i.e., vitamin b12, lld factor) |
42 |
| 435/87 |
Nucleoside |
91 |
| 435/88 |
Having a fused ring containing a six-membered ring having two n-atoms in the same ring (e.g., purine nucleosides, etc.) |
81 |
| 435/89 |
Nucleotide |
134 |
| 435/90 |
Dinucleotide (e.g., nad, etc.) |
51 |
| 435/92 |
Having a fused ring containing a six-membered ring having two n-atoms in the same ring (e.g., purine based mononucleotides, etc.) |
47 |
| 435/91.1 |
Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) |
3937 |
| 435/91.2 |
Acellular exponential or geometric amplification (e.g., pcr, etc.) |
5142 |
| 435/91.21 |
Involving the making of multiple rna copies |
251 |
| 435/91.5 |
Acellular preparation of polynucleotide |
415 |
| 435/91.53 |
Involving a hydrolase (3.) |
155 |
| 435/91.52 |
Involving a ligase (6.) |
179 |
| 435/91.51 |
Involving rna as a starting material or intermediate |
312 |
| 435/91.4 |
Modification or preparation of a recombinant dna vector |
536 |
| 435/91.41 |
By insertion or addition of one or more nucleotides |
585 |
| 435/91.42 |
Involving deletion of a nucleotide or nucleotides from a vector |
126 |
| 435/91.3 |
Polynucleotide contains only ribonucleotide monomers |
223 |
| 435/91.31 |
Involving catalytic ribonucleic acid |
289 |
| 435/91.32 |
Prepared from virus, prokaryotic acid |
82 |
| 435/91.33 |
Involving virus |
143 |
| 435/74 |
Preparing o-glycoside (e.g., glucosides, etc.) |
244 |
| 435/79 |
Oxygen atom of the saccharide radical is bonded to a cyclohexyl radical (e.g., kasugamycin, etc.) |
16 |
| 435/80 |
Cyclohexyl radical is substituted by two or more nitrogen atoms (e.g., destomycin, neamin, etc.) |
50 |
| 435/81 |
Cyclohexyl radical is attached directly to a nitrogen atom of two or more n-c(=n)-n radicals (e.g., streptomycin, etc.) |
6 |
| 435/82 |
Having two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl radical (e.g., ambutyrosin, ribostamycin, etc.) |
12 |
| 435/83 |
Containing three or more saccharide radicals (e.g., liquidomycin, neomycin, lividomycin, etc.) |
8 |
| 435/78 |
Oxygen atom of the saccharide radical is directly bonded to a condensed ring system having three or more carboxyclic rings (e.g., dauomycin, adriamycin, etc.) |
101 |
| 435/77 |
Oxygen atom of the saccharide radical is directly linked through only acyclic carbon atoms to a nonsaccharide heterocyclic ring (e.g., bleomycin, phleomycin, etc.) |
27 |
| 435/75 |
Oxygen of the saccharide radical is directly bonded to a nonsaccharide heterocyclic ring or a fused- or bridged-ring system which contains a nonsaccharide heterocyclic ring (e.g., coumermycin, novobiocin, etc.) |
133 |
| 435/76 |
The hetero ring has eight or more ring members and only oxygen as ring hetero atoms (e.g., erythromycin, spiramycin, nystatin, etc.) |
169 |
| 435/73 |
Preparing s-glycoside (e.g., lincomycin, etc.) |
16 |
| 435/95 |
Produced by the action of a beta-amylase (e.g., maltose by the action of beta-amylase on amylose, etc.) |
114 |
| 435/99 |
Produced by the action of a carbohydrase (e.g., maltose by the action of alpha amylase on starch, etc.) |
423 |
| 435/97 |
Produced by the action of a glycosyl transferase (e.g., alpha, beta, gamma-cyclodextrins by the action of glycosyl transferase on starch, etc.) |
249 |
| 435/98 |
Produced by the action of an alpha-1, 6-glucosidase (e.g., amylose debranched amylopectin by the action of pullulanase, etc.) |
97 |
| 435/96 |
Produced by the action of an exo-1.4 alpha glucosidase (e.g., dextrose by the action of glucoamylase on starch, etc.) |
191 |
| 435/94 |
Produced by the action of an isomerase (e.g., fructose by the action of xylose isomerase on glucose, etc.) |
230 |
| 435/43 |
Preparing compound having a 1-thia-4-aza-bicyclo (3.2.0) heptane ring system (e.g., penicillin, etc.) |
78 |
| 435/45 |
By acylation of the substituent in 6-position |
32 |
| 435/44 |
By desacylation of the substituent in 6-position |
30 |
| 435/46 |
In presence of phenyl acetic acid or phenyl acetamide or their derivatives |
16 |
| 435/47 |
Preparing compound having a 1-thia-5-aza-bicyclo (4.2.0) octane ring system (e.g., cephalosporin, etc.) |
96 |
| 435/50 |
By acylation of the substituent in the 7-position |
23 |
| 435/51 |
By desacylation of the substituent in the 7-position |
43 |
| 435/49 |
Cephalosporin c |
56 |
| 435/48 |
Di-substituted in 7-position |
23 |
| 435/65 |
Preparing compound other than saccharide containing a gibberellin nucleus (i.e., gibbane) |
4 |
| 435/64 |
Preparing compound other than saccharide containing a tetracycline nucleus (e.g., naphacene, etc.) |
25 |
| 435/66 |
Preparing compound other than saccharide containing alloxazine or isoalloxazine nucleus |
24 |
| 435/168 |
Preparing element or inorganic compound except carbon dioxide |
138 |
| 435/117 |
Preparing heterocyclic carbon compound having only o, n, s, se, or te as ring hetero atoms |
172 |
| 435/118 |
Containing two or more hetero rings |
268 |
| 435/119 |
Containing at least two hetero rings bridged or fused among themselves or bridged or fused with a common carbocyclic ring system, (e.g., rifamycin, etc.) |
516 |
| 435/121 |
Nitrogen as only ring hetero atom |
175 |
| 435/122 |
Containing six-membered hetero ring |
150 |
| 435/120 |
Nitrogen or oxygen hetero atom and at least one other diverse hetero ring atom in the same ring |
88 |
| 435/123 |
Oxygen as only ring hetero atom |
199 |
| 435/124 |
Containing a hetero ring of at least seven ring members (e.g., zearalenone, macrocyclic lactones, etc.) |
51 |
| 435/126 |
Containing five-membered hetero ring (e.g., griseofulvin, etc.) |
121 |
| 435/125 |
Containing six-membered hetero ring (e.g., fluorescein, etc.) |
215 |
| 435/166 |
Preparing hydrocarbon |
73 |
| 435/167 |
Only acyclic |
126 |
| 435/128 |
Preparing nitrogen-containing organic compound |
414 |
| 435/129 |
Amide (e.g., chloramphenicol, etc.) |
167 |
| 435/131 |
Preparing organic compound containing a metal or atom other than h, n, c, o, or halogen |
74 |
| 435/132 |
Preparing oxygen-containing organic compound |
230 |
| 435/135 |
Carboxylic acid ester |
576 |
| 435/136 |
Containing a carboxyl group |
428 |
| 435/140 |
Acetic acid |
85 |
| 435/146 |
Hydroxy carboxylic acid |
244 |
| 435/139 |
Lactic acid |
151 |
| 435/142 |
Polycarboxylic acid |
109 |
| 435/145 |
Dicarboxylic acid having four or less carbon atoms (e.g., fumaric, maleic, etc.) |
85 |
| 435/143 |
Having keto group (e.g., alpha-ketoglutaric acid, etc.) |
26 |
| 435/144 |
Tricarboxylic acid (e.g., citric acid, etc.) |
71 |
| 435/141 |
Propionic or butyric acid |
93 |
| 435/137 |
Sugar acid having five or more carbon atoms (i.e., aldonic, keto-aldonic, or saccharic acid) |
98 |
| 435/138 |
Alpha-ketogulonic acid (i.e., 2-ketogulonic acid) |
76 |
| 435/147 |
Containing carbonyl group |
141 |
| 435/148 |
Ketone |
153 |
| 435/150 |
Acetone containing product |
25 |
| 435/151 |
Substrate contains grain or cereal material |
7 |
| 435/154 |
Substrate contains inorganic compound, other than water |
6 |
| 435/153 |
Substrate contains inorganic nitrogen source |
5 |
| 435/152 |
Substrate contains protein as nitrogen source |
5 |
| 435/149 |
Cyclopentanone or cyclopentadione containing compound |
21 |
| 435/155 |
Containing hydroxy group |
247 |
| 435/157 |
Acyclic |
93 |
| 435/160 |
Butanol |
48 |
| 435/161 |
Ethanol |
350 |
| 435/162 |
Multiple stages of fermentation; multiple types of micro-organisms or reuse of micro-organisms |
138 |
| 435/163 |
Produced as by-product, or from waste, or from cellulosic material substrate |
106 |
| 435/165 |
Substrate contains cellulosic material |
113 |
| 435/164 |
Substrate contains sulphite waste liquor or citrus waste |
20 |
| 435/158 |
Polyhydric |
137 |
| 435/159 |
Glycerol |
22 |
| 435/156 |
Aromatic |
189 |
| 435/133 |
Containing quinone nucleus (i.e., quinoid structure) |
39 |
| 435/134 |
Fat; fatty oil; ester-type wax; higher fatty acid (i.e., having at least seven carbon atoms in an unbroken chain bound to a carboxyl group); oxidized oil or fat |
485 |
| 435/130 |
Preparing sulfur-containing organic compound |
119 |
| 435/42 |
Process involving micro-organisms of different genera in the same process, simultaneously |
232 |
| 435/69.1 |
Recombinant dna technique included in method of making a protein or polypeptide |
13178 |
| 435/69.3 |
Antigens |
1587 |
| 435/69.6 |
Blood proteins |
867 |
| 435/69.2 |
Enzyme inhibitors or activators |
564 |
| 435/69.7 |
Fusion proteins or polypeptides |
2378 |
| 435/69.4 |
Hormones and fragments thereof |
888 |
| 435/69.5 |
Lymphokines or monokines |
643 |
| 435/69.51 |
Interferons |
329 |
| 435/69.52 |
Interleukins |
419 |
| 435/69.8 |
Signal sequence (e.g., beta-galactosidase, etc.) |
457 |
| 435/69.9 |
Yeast derived |
117 |
| 435/71.1 |
Using a micro-organism to make a protein or polypeptide |
1688 |
| 435/71.2 |
Procaryotic micro-organism |
850 |
| 435/71.3 |
Antibiotic or toxin |
323 |
| 435/169 |
Using actinomycetales |
201 |
| 435/170 |
Using bacteria |
515 |
| 435/171 |
Using fungi |
345 |
| 435/70.1 |
Using tissue cell culture to make a protein or polypeptide |
1333 |
| 435/70.3 |
Animal tissue cell culture |
339 |
| 435/70.4 |
Blood (lymphoid) cell culture |
129 |
| 435/70.5 |
Producing interferons |
74 |
| 435/70.2 |
Fused or hybrid cells |
147 |
| 435/70.21 |
Producing monoclonal antibody |
973 |
| 435/821 |
Micro-organisms used in the destruction of hazardous or toxic waste |
46 |
| 435/317.1 |
Miscellaneous (e.g., subcellular parts of micro-organisms, etc.) |
217 |
| 435/972 |
Modified antibody (e.g., hybrid, bifunctional, etc.) |
51 |
| 435/969 |
Multiple layering of reactants |
133 |
| 435/808 |
Optical sensing apparatus |
543 |
| 435/810 |
Packaged device or kit |
2008 |
| 435/803 |
Physical recovery methods (e.g., chromatography, grinding) |
395 |
| 435/410 |
Plant cell or cell line, per se (e.g., transgenic, mutant, etc.); composition thereof; process of propagating, maintaining, or preserving plant cell or cell line; process of isolating or separating a plant cell or cell line; process of regenerating plant cells into tissue, plant part, or plant, per se, where no genotypic change occurs; medium therefore |
1166 |
| 435/412 |
Corn cell or cell line, per se |
1467 |
| 435/413 |
Herbicide resistant |
42 |
| 435/420 |
Culture, maintenance, or preservation techniques, per se |
224 |
| 435/422 |
Involving conifer cell or tissue (e.g., pine, spruce, fir, cedar, etc.) |
76 |
| 435/424 |
Involving corn cell or tissue |
1057 |
| 435/427 |
Involving cotton cell or tissue |
54 |
| 435/429 |
Involving potato cell or tissue |
27 |
| 435/421 |
Involving protoplast |
470 |
| 435/430 |
Involving regeneration or propagation into a plant or plant part |
1461 |
| 435/430.1 |
Involving callus or embryonic stage |
1357 |
| 435/426 |
Involving soybean cell or tissue |
671 |
| 435/428 |
Involving sunflower cell or tissue |
27 |
| 435/425 |
Involving tobacco cell or tissue |
26 |
| 435/423 |
Involving tomato cell or tissue |
25 |
| 435/431 |
Medium, per se, for culture, maintenance, regeneration, etc. |
148 |
| 435/419 |
Plant cell or cell line, per se, contains exogenous or foreign nucleic acid |
2718 |
| 435/418 |
Plant cell or cell line, per se, is pest or herbicide resistant or pest lethal |
596 |
| 435/417 |
Potato cell or cell line, per se |
91 |
| 435/415 |
Soybean cell or cell line, per se |
1290 |
| 435/416 |
Sunflower cell or cell line, per se |
62 |
| 435/414 |
Tobacco cell or cell line, per se |
113 |
| 435/411 |
Tomato cell or cell line, per se |
105 |
| 435/962 |
Prevention or removal of interfering materials or reactants or other treatment to enhance results (e.g., determining or preventing nonspecific binding, etc.) |
547 |
| 435/440 |
Process of mutation, cell fusion, or genetic modification |
968 |
| 435/449 |
Fusion of cells |
110 |
| 435/450 |
Employing electric current |
38 |
| 435/451 |
One of the fusing cells is a human antibody-producing cell |
45 |
| 435/454 |
One of the fusing cells is a microorganism (e.g., prokaryote, fungus, etc.) |
31 |
| 435/452 |
One of the fusing cells is a mouse antibody-producing cell |
130 |
| 435/453 |
One of the fusing cells is a plant cell |
12 |
| 435/468 |
Introduction of a polynucleotide molecule into or rearrangement of a nucleic acid within a plant cell |
2401 |
| 435/469 |
Introduction via agrobacterium |
255 |
| 435/470 |
Introduction via electroporation, particle, fiber or microprojectile mediated insertion, or injection |
198 |
| 435/471 |
Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within a microorganism (e.g., bacteria, protozoa, bacteriophage, etc.) |
1422 |
| 435/473 |
The polynucleotide contains a transposon |
91 |
| 435/474 |
The polynucleotide is a cosmid |
17 |
| 435/476 |
The polynucleotide is a plasmid or episome |
265 |
| 435/485 |
Microorganism of the genus bacillus is a host for the plasmid or episome |
85 |
| 435/487 |
Microorganism of the genus brevibacterium or the genus corynebacterium is a host for the plasmid or episome |
20 |
| 435/488 |
Microorganism of the genus escherichia is a host for the plasmid or episome |
313 |
| 435/486 |
Microorganism of the genus streptomyces is a host for the plasmid or episome |
63 |
| 435/484 |
Mycelial fungus is a host for the plasmid or episome |
68 |
| 435/479 |
Plasmid or episome confers the ability to utilize directly a compound which a wild type microorganism is unable to utilize |
36 |
| 435/481 |
Plasmid or episome contains a gene which complements a nutritional deficiency mutation |
46 |
| 435/482 |
Plasmid or episome contains a gene which confers resistance to metal, silicon, selenium, or tellurium toxicity |
11 |
| 435/478 |
Plasmid or episome contains at least part of a gene encoding a restriction endonuclease or modification enzyme |
41 |
| 435/480 |
Plasmid or episome contains at least part of a gene encoding a toxin or encoding for virulence or pathogenicity |
71 |
| 435/477 |
Plasmid or episome contains dna targeting homologous recombination to bacteriophage, viral, or chromosomal dna within a microorganism |
197 |
| 435/489 |
Plural nonidentical plasmids are introduced into a host microorganism or culture thereof (e.g., plasmid is part of a library, etc.) |
67 |
| 435/483 |
Yeast is a host for the plasmid or episome |
240 |
| 435/490 |
The polynucleotide is an unbranched linear fragment |
36 |
| 435/472 |
The polynucleotide is encapsidated within a bacteriophage, bacteriophage coat, or transducing particle |
122 |
| 435/475 |
The polynucleotide is unencapsidated bacteriophage or viral nucleic acid |
77 |
| 435/455 |
Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell |
2797 |
| 435/467 |
Introducing an oncogene to establish a cell line |
71 |
| 435/465 |
Involving co-transfection |
189 |
| 435/461 |
Involving electroporation |
117 |
| 435/464 |
Involving gene duplication within the cell (e.g., amplification, co-amplification, etc.) |
51 |
| 435/463 |
Involving general or homologous recombination (e.g., gene targeting, etc.) |
283 |
| 435/460 |
Involving laser treatment of the cell before or during transfection |
16 |
| 435/459 |
Involving particle-mediated transfection (i.e., biolistic transfection) |
80 |
| 435/462 |
Involving site-specific recombination (e.g., cre-lox, etc.) |
143 |
| 435/466 |
The polynucleotide is a shuttle vector or a transiently replicating hybrid vector |
84 |
| 435/458 |
The polynucleotide is coated with or encapsulated within a lipid containing material (e.g., liposome, etc.) |
386 |
| 435/456 |
The polynucleotide is encapsidated within a virus or viral coat |
835 |
| 435/457 |
Helper virus is present |
169 |
| 435/441 |
Mutation employing a chemical mutagenic agent |
105 |
| 435/442 |
By replacement of standard nucleic acid base with base analog (e.g., 5-bromouracil, etc.) |
29 |
| 435/444 |
By use of alkylating agent (e.g., nitrosoguanidine, etc.) |
49 |
| 435/443 |
By use of intercalating agent (e.g., acridine orange, etc.) |
18 |
| 435/445 |
By use of oxidative deamination agent (e.g., nitrous acid, etc.) |
19 |
| 435/446 |
Mutation employing radiation or electricity |
26 |
| 435/448 |
Ultraviolet irradiation |
50 |
| 435/447 |
X-ray irradiation |
15 |
| 435/262 |
Process of utilizing an enzyme or micro-organism to destroy hazardous or toxic waste, liberate, separate, or purify a preexisting compound or composition therefore; cleaning objects or textiles |
706 |
| 435/264 |
Cleaning using a micro-organism or enzyme |
420 |
| 435/265 |
Depilating hides, bating, or hide treating using enzyme or micro-organism |
46 |
| 435/262.5 |
Destruction of hazardous or toxic waste |
667 |
| 435/281 |
Petroleum oil or shale oil treating |
157 |
| 435/282 |
Desulfurizing |
80 |
| 435/280 |
Resolution of optical isomers or purification of organic compounds or composition containing same |
634 |
| 435/263 |
Textile treating |
183 |
| 435/267 |
Treating animal or plant material or micro-organism |
340 |
| 435/274 |
Carbohydrate material recovered or purified |
113 |
| 435/277 |
Cellulose (e.g., plant fibers, etc.) |
154 |
| 435/279 |
Hemp or flax treating |
6 |
| 435/278 |
Producing paper pulp |
158 |
| 435/275 |
Pectin or starch |
47 |
| 435/276 |
Sugar (e.g., molasses treatment, etc.) |
39 |
| 435/271 |
Glyceridic oil, fat, ester-type wax, or higher fatty acid recovered or purified |
42 |
| 435/272 |
Proteinaceous material recovered or purified |
153 |
| 435/273 |
Collagen or gelatin |
67 |
| 435/270 |
Removing nucleic acid from intact or disrupted cell |
139 |
| 435/269 |
Treating blood fraction |
64 |
| 435/268 |
Treating organ or animal secretion |
80 |
| 435/266 |
Treating gas, emulsion, or foam |
161 |
| | Related to subclasses | |
| 435/973 |
Simultaneous determination of more than one analyte |
337 |
| 435/804 |
Single cell protein |
107 |
| 435/242 |
Spore forming or isolating process |
64 |
| 435/967 |
Standards, controls, materials (e.g., validation studies, buffer systems, etc.) |
199 |
| 435/820 |
Subcellular parts of micro-organisms |
97 |
| 435/805 |
Test papers |
757 |
| 435/970 |
Test strip or test slide |
589 |
| 435/173.1 |
Treatment of micro-organisms or enzymes with electrical or wave energy (e.g., magnetism, sonic waves, etc.) |
295 |
| 435/173.4 |
Cell membrane or cell surface is target |
98 |
| 435/173.7 |
Lytic effect produced (e.g., disruption of cell membrane for release of subcellular parts; e.g., nucleic acids, etc.) |
79 |
| 435/173.5 |
Membrane permeability increased |
71 |
| 435/173.6 |
Electroporation |
134 |
| 435/173.9 |
Concentration, separation, or purification of micro-organisms |
115 |
| 435/173.2 |
Enzyme treated |
40 |
| 435/173.8 |
Metabolism of micro-organism enhanced (e.g., growth enhancement or increased production of microbial product) |
84 |
| 435/173.3 |
Modification of viruses (e.g., attenuation, etc.) |
85 |
| 435/320.1 |
Vector, per se (e.g., plasmid, hybrid plasmid, cosmid, viral vector, bacteriophage vector, etc.) bacteriophage vector, etc.) |
19701 |
| 435/235.1 |
Virus or bacteriophage, except for viral vector or bacteriophage vector; composition thereof; preparation or purification thereof; production of viral subunits; media for propagating |
2311 |
| 435/236 |
Inactivation or attenuation; producing viral subunits |
674 |
| 435/238 |
By chemical treatment |
253 |
| 435/237 |
By serial passage of virus |
237 |
| 435/239 |
Recovery or purification |
514 |